Molecules/SPARTALIZUMAB

SPARTALIZUMAB

Molecular Identity

AntibodyPhase 3

Mechanism of action: Programmed cell death protein 1 antagonist

Molecular Formula

0.00

Molecular Weight

g/mol

ANTI-PD1 MONOCLONAL ANTIBODY PDR001ESPARTALIZUMABNVP-LZV184PDR-001PDR001SPARTALIZUMAB

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Trials and conditions connected to SPARTALIZUMAB

Loading drug network...